Skip to content
Business Times – Lifestyle
Author:
Appili Therapeutics Inc.
Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program
July 3, 2026
Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results
June 26, 2026
Appili Therapeutics to Exhibit at World Vaccine Congress Washington
March 30, 2026